47628例输血前四项检测结果的分析

摘要

目的 了解拟输血患者HBsAg、抗-HCV、梅毒TP、抗-HIV感染情况，预防和避免医院感染和医疗纠纷的发生，提醒医务人员注意生物防护与自我保护.方法 采用酶联免疫法对我院2009年1月至2011年12月47628例拟输血患者进行以上四项检测，按项目、姓别、年龄段进行分组分析.结果 47628例患者中，总阳性6316例，总阳性率13.26%.其中HBsAg阳性4308例，阳性率为9.04%；抗-HCV阳性772例，阳性率为1.62%；梅毒-TP阳性1212例，阳性率为2.54%；抗-HIV阳性24例，抗-HIV阳性率为0.05%；梅毒TP男性略高于女性；抗-HCV、梅毒阳性率TP有随年龄增高而增高的趋势.结论 通过对受血者输血前四项检测，明确患者的健康状况，保护医患双方的利益，也可发现隐性感染者，为临床治疗、经血液传播疾病引起的医患纠纷提供证据.%　　Objective To understand the infection status of HBsAg, anti-HCV, syphilisTP, anti-HIV in intended blood transfusion patients, prevent and avoid infection in hospital and medical disputes, remind the attention of medical staff to biological protection and self protection. Methods Using an enzyme-linked immunosorbent assay method performed the four pre-transfusion detection for 47628 patients in my hospital from January 2009 to December 2011 and subgroup analysis according to project, gender and age. Results There were 6316 positive cases in 47628 patients, the total positive rate was 13.26%. Of which 4308 cases were HBsAg positive, the positive rate was 2.54%.24 cases were HIV positive, the total positive rate was 0.05%.Male syphilisTP was slightly higher than female, the syphilis positive rate increased with the increase of the age. Conclusion By the four detection of pre-transfusion,we may make clear the patients’ health status, protect the interests of both medical staff and patients, and can also found some asymptomatic positive patients with blood transmitted diseases and provide evidence for clinical treatment of blood transmitted diseases caused by medical disputes.